Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 1/2017

01-02-2017 | Acknowledgement

Thank you to the reviewers

Author: J. W. F. van Mil

Published in: International Journal of Clinical Pharmacy | Issue 1/2017

Login to get access

Excerpt

In 2016, the International Journal of Clinical Pharmacy received around 650 contributions. Many reviewers helped us to select the manuscripts that were within the scope of the journal, and presented something new or of value. We are very, very thankful for their help. Without their dedication, we could not produce such a valuable and high quality journal. …
Metadata
Title
Thank you to the reviewers
Author
J. W. F. van Mil
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2017
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0427-5

Other articles of this Issue 1/2017

International Journal of Clinical Pharmacy 1/2017 Go to the issue

Short Research Report

Evaluation of nucleoside reverse transcriptase inhibitor dosing during continuous veno-venous hemofiltration

Research Article

Patients’ understanding and use of analgesia for postnatal pain following hospital discharge

Research Article

Effects of economic recession on elderly patients’ perceptions of access to health care and medicines in Portugal

Short Research Report

Improvement of time in therapeutic range with warfarin by pharmaceutical intervention

Research Article

Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease

Research Article

Availability and quality of illegitimate somatropin products obtained from the Internet
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits